Log In
Print
BCIQ
Print
Print this Print this
 

epoetin alfa (Binocrit) (HX575)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBiosimilar version of erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Latest Stage of DevelopmentMarketed
IndicationAnemia
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today